Einen vollständigen und aktuellen Überblick über meine wissenschaftlichen Veröffentlichungen erhalten Sie auch unter folgendem Link: >> PubMed <<
Paper
2025
Martin L, Martin C, Peine A, Imöhl M, Kersten A, Kramann R, Saritas T, Marx N, Dreher M, Marx G, Simon TP. Implementation and One-Year Evaluation of Proenkephalin A in Critical Care. Int J Mol Sci. 2025 Mar 13;26(6):2602. doi: 10.3390/ijms26062602.
Hof H, Singer S, Steiner I, Bertsch D, Kirstahler M, Oberdorfer K, Imöhl M, van der Linden M.
Pneumokokkensepsis 2015 - 2022: Überlegungen zu Impfstrategien. Dtsch Med Wochenschr. 2025 Apr;150(8):e11-e17. doi: 10.1055/a-2506-4928.
2024
Mohamed AA, Sahin C, Berres ML, Beetz O, Websky MV, Vogel T, Vondran FWR, Bruners P, Imöhl M, Frank K, Vogt E, Singh BP, Eble MJ. The prognostic utility of IGF-1 in hepatocellular carcinoma treated with stereotactic body radiotherapy. Clin Transl Radiat Oncol. 2024 Nov 12;50:100887. doi: 10.1016/j.ctro.2024.100887. eCollection 2025 Jan.
2023
Klingel H, Krüttgen A, Imöhl M, Kleines M.
Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions. Clin Exp Vaccine Res. 2023 Jan;12(1):60-69. doi: 10.7774/cevr.2023.12.1.60. Epub 2023 Jan 31.PMID: 36844685.
2022
Klingel H, Lauen M, Krüttgen A, Imöhl M, Kleines M.
Severity of adverse reactions is associated with T-cell response in mRNA-1273 vaccinated health care workers. Clin Exp Vaccine Res. 2022 Jan;11(1):121-124. doi: 10.7774/cevr.2022.11.1.121. Epub 2022 Jan 31.PMID: 35223673.
Krüttgen A, Haase G, Haefner H, Imöhl M, Kleines M.
Large inter-individual variability of cellular and humoral immunological responses to mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in health care workers. Clin Exp Vaccine Res. 2022 Jan;11(1):96-103. doi: 10.7774/cevr.2022.11.1.96. Epub 2022 Jan 31.PMID: 35223670.
2021
Rose MA, Laurenz M, Sprenger R, Imöhl M, van der Linden M.
Nasopharyngeal Carriage in Children After the Introduction of Generalized Infant Pneumococcal Conjugate Vaccine Immunization in Germany. Front Med (Lausanne). 2021 Sep 13;8:719481. doi: 10.3389/fmed.2021.719481. eCollection 2021.PMID: 34589501.
Krüttgen A, Lauen M, Klingel H, Imöhl M, Kleines M.
Two novel SARS-CoV-2 surrogate virus neutralization assays are suitable for assessing successful immunization with mRNA-1273. J Virol Methods. 2022 Jan;299:114297. doi: 10.1016/j.jviromet.2021.114297. Epub 2021 Sep 23.PMID: 34563583.
Krüttgen A, Klingel H, Haase G, Haefner H, Imöhl M, Kleines M.
Evaluation of the QuantiFERON SARS-CoV-2 interferon-ɣ release assay in mRNA-1273 vaccinated health care workers. J Virol Methods. 2021 Dec;298:114295. doi: 10.1016/j.jviromet.2021.114295. Epub 2021 Sep 20.PMID: 34555429.
Imöhl M, Perniciaro S, Busse A, van der Linden M.
Bacterial Spectrum of Spontaneously Ruptured Otitis Media in a 7-Year, Longitudinal, Multicenter, Epidemiological Cross-Sectional Study in Germany. Front Med (Lausanne). 2021 May 20;8:675225. doi: 10.3389/fmed.2021.675225. eCollection 2021.PMID: 3409517.
Krüttgen A, Cornelissen CG, Dreher M, Hornef MW, Imöhl M, Kleines M.
Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit. J Virol Methods. 2021 Feb;288:114024. doi: 10.1016/j.jviromet.2020.114024. Epub 2020 Nov 20.
Krüttgen A, Cornelissen CG, Dreher M, Hornef MW, Imöhl M, Kleines M.
Determination of SARS-CoV-2 antibodies with assays from Diasorin, Roche and IDvet. J Virol Methods. 2021 Jan;287:113978. doi: 10.1016/j.jviromet.2020.113978. Epub 2020 Sep 23.
2020
Krüttgen A, Cornelissen CG, Dreher M, Hornef M, Imöhl M, Kleines M.
Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG. J Clin Virol. 2020 Jul;128:104394. doi: 10.1016/j.jcv.2020.104394. Epub 2020 Apr 29.
Evliyaoglu O, Imöhl M, Weiskirchen R, van Helden J.
Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome. Clin Chem Lab Med. 2020 Jul 28;58(8):1291-1301. doi: 10.1515/cclm-2019-1059.
2019
Evliyaoglu O, van Helden J, Jaruschewski S, Imöhl M, Weiskirchen R.
Reference change values of M-protein, free light chain and immunoglobulins in monoclonal gammopathy. Clin Biochem. 2019 Dec;74:42-46. doi: 10.1016/j.clinbiochem.2019.09.004. Epub 2019 Sep 14.
van der Linden M, Imöhl M, Perniciaro S.
Limited indirect effects of an infant pneumococcal vaccination program in an aging population. PLoS One. 2019 Aug 1;14(8):e0220453. doi: 10.1371/journal.pone.0220453. eCollection 2019.
Perniciaro S, Imöhl M, Fitzner C, van der Linden M.
Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany. PLoS One. 2019 Jan 9;14(1):e0210278. doi: 10.1371/journal.pone.0210278. eCollection 2019.
Evliyaoglu O, van Helden J, Imöhl M, Weiskirchen R.
Vitamin B1 interpretation: Erroneous higher levels in non-anemic populations. Nutrition. 2019 Apr;60:25-29. doi: 10.1016/j.nut.2018.09.002. Epub 2018 Sep 5.
2018
Perniciaro S, Imöhl M, van der Linden M.
Invasive Pneumococcal Disease in Refugee Children, Germany. Emerg Infect Dis. 2018 Oct;24(10):1934-1936. doi: 10.3201/eid2410.180253.
Evliyaoglu O, van Helden J, Imöhl M, Weiskirchen R.
Mining the Age-Dependent Reference Intervals of B Vitamins from Routine Laboratory Test Results. Lab Med. 2019 Jan 1;50(1):54-63. doi: 10.1093/labmed/lmy045.
2017
Imöhl M, Fitzner C, Perniciaro S, van der Linden M.
Epidemiology and distribution of 10 superantigens among invasive Streptococcus pyogenes disease in Germany from 2009 to 2014.
PLoS One. 2017 Jul 18;12(7):e0180757. doi: 10.1371/journal.pone.0180757. eCollection 2017.
Schmitz J, van der Linden M, Al-Lahham A, Levina N, Pletz MW, Imöhl M.
Fluoroquinolone resistance in Streptococcus pneumoniae isolates in Germany from 2004-2005 to 2014-2015. Int J Med Microbiol. 2017 Jun;307(4-5):216-222. doi: 10.1016/j.ijmm.2017.04.003. Epub 2017 Apr 19.
2016
van der Linden M, Falkenhorst G, Perniciaro S, Fitzner C, Imöhl M.
Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany.
PLoS One. 2016 Aug 15;11(8):e0161257. doi: 10.1371/journal.pone.0161257.
Weinberger R, van der Linden M, Imöhl M, von Kries R.
Vaccine effectiveness of PCV13 in a 3+1 vaccination schedule.
Vaccine. 2016 Apr 19;34(18):2062-5. doi: 10.1016/j.vaccine.2016.02.043.
2015
Weinberger R, Falkenhorst G, Bogdan C, van der Linden M, Imöhl M, von Kries R.
Incidence of invasive pneumococcal disease in 5-15 year old children with and without comorbidities in Germany after the introduction of PCV13: Implications for vaccinating children with comorbidities. Vaccine. 2015 Nov 27;33(48):6617-21. doi: 10.1016/j.vaccine.2015.10.102. Epub 2015 Nov 1.
Imöhl M, van der Linden M.
Antimicrobial susceptibility of invasive Streptococcus pyogenes isolates in Germany during 2003-2013. PLoS One. 2015 Sep 4;10(9):e0137313. doi: 10.1371/journal.pone.0137313. eCollection 2015.
Imöhl M, Reinert RR, van der Linden M.
Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in Germany.
Int J Med Microbiol. 2015 Oct;305(7):776-83. doi: 10.1016/j.ijmm.2015.08.031. Epub 2015 Aug 22.
van der Linden M, Falkenhorst G, Perniciaro S, Imöhl M.
Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany. PLoS One. 2015 Jul 1;10(7):e0131494. doi: 10.1371/journal.pone.0131494. eCollection 2015.
van der Linden M, Perniciaro S, Imöhl M.
Increase of serotypes 15A and 23B in IPD in Germany in the post-PCV13 vaccination era.
BMC Infect Dis. 2015 May 5;15:207. doi: 10.1186/s12879-015-0941-9.
Imöhl M, Möller J, Reinert RR, Perniciaro S, van der Linden M, Aktas O.
Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: Results of 20 years of nationwide surveillance in Germany.
BMC Infect Dis. 2015 Feb 14;15:61. doi: 10.1186/s12879-015-0787-1.
Imöhl M, Ritter K.
Versand und Transport von Laborproben und infektiösem Material: Gefahrgutrechtliche Hinweise nach ADR 2013 und der 24. ADR-Änderungsverordnung (Oktober 2014). Arbeitsmedizin Sozialmedizin Umweltmedizin (ASU) - Zeitschrift für Medizinische Prävention.
2015; 50 (8): 565-570.
Weiss S, Falkenhorst G, van der Linden M, Imöhl M, von Kries R.
Impact of 10/13-valent pneumococcal conjugate vaccines on incidence of invasive pneumococcal disease in children <16 years in Germany (2009-2012). Euro Surveill. 2015 Mar 12;20(10):21057.
2014
van der Linden M*, Imöhl M*, Busse A, Rose M, Adam D.
Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany. Eur J Pediatr.2015 Mar;174(3):355-64. doi: 10.1007/s00431-014-2409-0. Epub 2014 Aug 30. (*contributed equally)
Imöhl M, Reinert RR, Tulkens PM, van der Linden M.
Penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effect on susceptibility categorisation in Germany (1997-2013). Eur J Clin Microbiol Infect Dis. 2014 Nov;33(11):2035-40. doi: 10.1007/s10096-014-2174-z. Epub 2014 Jun 15.
Imöhl M, van der Linden M.
Invasive Pneumokokkenerkrankungen in Deutschland im Zeitalter der Pneumokokken Konjugat-Impfung. Dtsch Med Wochenschr. 2014 Jun;139(25-26):1346-51. doi: 10.1055/s-0034-1370126. Epub 2014 Jun 10.
2013
Epidemiologie invasiver Streptokokkenerkrankungen in Deutschland.
Der Mikrobiologe. 2013; 23(3): 150-165.
Versand und Transport von Laborproben und infektiösem Material.
Der Mikrobiologe. 2013; 23(2): 103-108.
van der Linden M, Winkel N, Küntzel S, Farkas A, Perniciaro SR, Reinert RR, Imöhl M.
Epidemiology of Streptococcus pneumoniae serogroup 6 isolates from IPD in children and adults in Germany. PLoS One. 2013 Apr 9;8(4):e60848. doi: 10.1371/journal.pone.0060848.
van der Linden M, Reinert RR, Kern WV, Imöhl M.
Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children.
BMC Infect Dis. 2013 Feb 5;13:70. doi: 10.1186/1471-2334-13-70.
2012
van der Linden M, Weiß S, Falkenhorst G, Siedler A, Imöhl M, von Kries R.
Four years of universal pneumococcal conjugate infant vaccination in Germany: Impact on incidence of invasive pneumococcal disease and serotype distribution in children.
Vaccine. 2012 Aug 31;30(40):5880-5. Epub 2012 Jul 4.
2011
Lâm TT, Claus H, Elias J, Hellenbrand W, Imöhl M, Prelog M, Sing A, van der Linden M, Vogel U. Infections with Pneumococci, Menigococci, H. influenzae and Diphtheria in Germany: the RKI Reference Network for Invasive Bacterial Infections (IBI) at the 5th Würzburg Workshop on Epidemiology, Prevention and Therapy for Invasive Meningococcal Diseases 2010 (Meeting Report). Gesundheitswesen. 2012 Nov;74(11):747-53. doi: 10.1055/s-0031-1286269. Epub 2011 Dec 27.
Imöhl M, van der Linden M, Reinert RR, Ritter K.
Invasive Group A Streptococcal Disease and Association with Varicella in Germany, 1996-2009.
FEMS Immunol Med Microbiol. 2011 Jun;62(1):101-9. doi: 10.1111/j.1574-695X.2011.00788.x. Epub 2011 Mar 2.
Krüttgen A, Razavi S, Imöhl M, Ritter K.
Real-time PCR assay and a synthetic positive-control for the rapid and sensitive detection of the emerging resistance gene New Dehli Metallo-b-lactamase-1 (blaNDM-1).
Med Microbiol Immunol. 2011 May;200(2):137-41. Epub 2011 Feb 25.
2010
Imöhl M, Reinert RR, Mutscher C, van der Linden M.
Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008. BMC Microbiol. 2010 Nov 25;10:299.
Horster S, Laubender RP, Lehmeyer L, Ankerst DP, Eberle J, Reinert R, Imöhl M, van der Linden M, Schweiger B, Bogner JR. Influence of antiretroviral therapy on immunogenicity of simultaneous vaccinations against influenza, pneumococcal disease and hepatitis A and B in human immunodeficiency virus positive individuals. J Infect. 2010 Dec;61(6):484-91. Epub 2010 Sep 25.
Imöhl M, Reinert RR, van der Linden M.
Temporal variations among invasive pneumococcal disease serotypes in children and adults in Germany, 1992-2008. Int J Microbiol, doi:10.1155/2010/874189.
Meedt B, Gharavi B, Imöhl M, Becker J-C.
Multi-organ failure in a previously healthy 10 year old boy. Streptococcal Toxic Shock Syndrome (STSS) – a rare differential diagnosis. Klin Padiatr, 2010 Sep;222(5):310-1. Epub 2010 Jun 16.
Imöhl M, van der Linden M, Mutscher C, Reinert RR.
Serotype distribution of invasive pneumococcal disease during the first 60 days of life.
Vaccine, 2010 Jul 5;28(30):4758-4762. Epub 2010 May 14.
Imöhl M, Rückinger
S, van der Linden M.
Pneumokokkenerkrankungen bei Kindern – Epidemiologie invasiver Pneumokokkenerkrankungen bei Kindern in Deutschland von 1997 bis 2009 und Effekte der Einführung der Pneumokokken-Konjugatimpfung.
Ärztliche Praxis Pädiatrie 2/2010: 32-33.
Imöhl M, Reinert RR, Ocklenburg C, van der Linden M.
Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease. J Clin Microbiol. 2010 Apr;48(4):1291-6. Epub 2010 Jan 27.
Imöhl M, Reinert RR, Ocklenburg C, van der Linden M.
Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007. FEMS Immunol Med Microbiol. 2010 Apr;58(3):389-96. Epub 2010 Jan 19.
Imöhl M, Reinert RR, van der Linden M.
Serotype-specific penicillin resistance of Streptococcus pneumoniae in Germany from 1992 to 2008. Int J Med Microbiol. 2010 Jun;300(5):324-30. Epub 2010 Jan 13.
2009
Imöhl M, Reinert RR, van der Linden M.
Adult invasive pneumococcal disease between 2003 and 2006 in North-Rhine Westphalia, Germany: serotype distribution before recommendation for general pneumococcal conjugate vaccination for children <2 years of age. Clin Microbiol Infect. 2009 Nov;15(11):1008-12. Epub 2009 Jul 20.
Imöhl M, Reinert RR, van der Linden M.
Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.
Int J Med Microbiol. 2010 Apr;300(4):237-47. Epub 2009 Jul 14.
Imöhl M, Reinert RR, van der Linden M.
New penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effects on susceptibility categorisation in Germany (1992-2008). Int J Antimicrob Agents. 2009 Sep;34(3):271-3. Epub 2009 May 5.
2007
Bulut D, Albrecht N, Imöhl M, Günesdogan B, Bulut-Streich N, Börgel J, Hanefeld C, Krieg M, Mügge A. Hormonal Status Modulates Circulating Endothelial Progenitor Cells. Clin Res Cardiol 2007; 96(5): 258-263. Epub 2007 Feb 26.
Wilhelm M, Wittsiepe J, Lemm F, Ranft U, Krämer U, Fürst P, Röseler S-C, Greshake M, Imöhl M, Eberwein G, Winneke G. The Duisburg birth cohort study: influence of the prenatal exposure to PCDD/Fs and dioxine-like PCBs on thyroid hormone status in newborns and neurodevelopment of infants until the age of 24 months. Mutat Res. 2008 Jul-Aug;659(1-2):83-92. Epub 2007 Nov 12. Review.
Cao Y, Winneke G, Wilhelm M, Wittsiepe J, Lemm F, Fürst P, Ranft U, Imöhl M, Kraft M, Oesch-Bartlomowicz B, Krämer U. Environmental Exposure to Dioxins and Polychlorinated Biphenyls Reduce Levels of Gonadal Hormones in Newborns: Results from the Duisburg Cohort Study. Int J Hyg Environ Health. 2008; 211: 30-39. Epub 2007 Jul 30.
2006
Merget R, Sander I, Rozynek P, Heinze E, Imoehl M, Raulf-Heimsoth M, Bruening T. Occupational IgE-mediated asthma due to Penicillium camemberti in a dry sausage packer. Respiration. 2008;76(1):109-11. Epub 2006 Nov 14.
2003
Imöhl M, Stachon A, Krieg M.
Review: Diagnose und Differentialdiagnose des Cushing-Syndroms
J Lab Med 2003; 27: 43-52
2002
Imöhl M, Köditz R, Stachon A, Müller K-M, Nicolas V, Pfeilschifter J, Krieg M. Katecholaminabhängiges hereditäres Cushing-Syndrom - Verlaufsbeobachtung nach einseitiger Adrenalektomie. Med Klin 2002; 97: 747-53
Stachon A, Sondermann N, Imöhl M, Krieg M.
Nucleated red blood cells indicate high risk of in-hospital mortality
J Lab Clin Med 2002; 140: 407-12
Abstracts
2022
M. van der Linden, M. Imöhl and A. Itzek.
Immediate re-emergence of invasive pneumococcal disease in Germany after strong reduction throughout SARS-CoV-2 pandemic lockdown.
32nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Lisbon, Portugal, 23 - 26 April 2022. Poster.
M. van der Linden, A. Itzek, S. Perniciaro and M. Imöhl.
Fall and rise of invasive pneumococcal disease among children in Germany.
40th Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID), Athens, Greece, 9 - 13 May 2022. E-Poster.
K. Maruhn, A. Itzek, M. Imoehl, M. van der Linden.
Development of a pipeline for genome sequencing based surveillance of pneumococcal infections. 12th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-12), Toronto, Canada, 19-23 June, 2022. Poster.
2021
M. van der Linden, M. Imöhl and A. Itzek.
Invasive pneumococcal disease among adults in Germany: impact of infant vaccination and COVID-19 pandemic. 31st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Online, 9 - 12 July 2020. Poster.
M. van der Linden, A. Itzek and M. Imöhl.
Invasive pneumococcal disease among children in Germany, effects of conjugate vaccination and COVID pandemic. 39th Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID), Geneva, Switzerland (Virtual), 24 - 28 May 2021. E-Poster.
2020
M. van der Linden, A. Itzek, S. Perniciaro and M. Imöhl.
Invasive pneumococcal disease among children in Germany, ten years after PCV13 introduction.
38th Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID), Virtual Meeting, 26 - 29 Oct 2020. E-Poster.
2019
M. van der Linden, S. Perniciaro and M. Imöhl.
Effects of 9 years of immunization with higher-valent pneumococcal conjugate vaccines on children in Germany and coverage of future vaccine formulations. 37th Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID), Ljubljana, Slovenia, 6 - 11 Mai 2019. E-Poster.
S. Perniciaro, M. Imöhl, M. van der Linden.
Which Serotypes Will Punch Back After Third-Generation Pneumococcal Conjugate Vaccination in Germany? 14th European meeting on the Molecular Biology of the Pneumococcus. Europneumo 2019, Greifswald, Germany, 11 - 14 June 2019. Poster.
2018
S. Perniciaro, M. Imöhl and M. van der Linden.
Reduzierte Effekte der pädiatrischen Pneumokokken-Konjugatimpfung auf invasive
Pneumokokkenerkrankungen bei Erwachsenen in Deutschland. 59. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V. (DGP), Dresden, Germany, 14-17 March 2018. Poster.
M. van der Linden, S. Perniciaro, and M. Imöhl.
Reduced effect of the pediatric pneumococcal conjugate vaccination on invasive pneumococcal disease in adults in Germany. 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Madrid, Spain, 21 - 24 April 2018. Poster.
M. van der Linden, S. Perniciaro and M. Imöhl.
Effects of 8 years of immunization with higher-valent pneumococcal conjugate vaccines among children in Germany. 36th Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID), Malmö, Sweden, 23 Mai - 2 June 2018. E-Poster.
S. Perniciaro, M. Imöhl, and M. van der Linden.
Invasive Pneumococcal Disease in Refugee Children Residing in Germany: A Possible Niche for Vaccine-Type and Antibiotic-Resistant Isolates. 36th Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID), Malmö, Sweden, 23 Mai - 2 June 2018. E-Poster.
S. Perniciaro, M. Imöhl, and M. van der Linden.
Increasing role of serotype 3 in invasive pneumococcal disease in Germany, 2000-2016.
11th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-11), Melbourne, Australia, April 15-19, 2018. Poster.
J. Loogen, M. Imöhl, S. Perniciaro and M. van der Linden.
Novel serogroup 24 isolates from invasive pneumococcal disease in Germany. 11th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-11), Melbourne, Australia, April 15-19, 2018. Poster.
2017
M. Rose, M. Imöhl, M. Laurenz, R. Sprenger, M. van der Linden.
Impact of Pneumococcal Immunization on Antibiotic Resistance - Results of the German Colonization-Surveillance Study. 10th World Congress of the World Society for Pediatric Infectious Diseases (WSPID), Shenzhen, China, December 2-5, 2017. E-Poster EP03.
M. van der Linden, S. Perniciaro, M. Imöhl.
Dynamics of pneumococcal serotypes and antibiotic resistance in the post childhood vaccination era in Germany. 13th European meeting on the Molecular Biology of the Pneumococcus (Europneumo), Karolinska Institute, Stockholm, Sweden, June 27-30, 2017. Poster.
M. Rose, M. Imöhl, M. Laurenz, R. Sprenger, M. van der Linden.
Entwicklung der nasopharyngealen Besiedlung bei unter sechsjährigen Kindern seit Einführung der Pneumokokken-Konjugatimpfung in Deutschland. 25. Jahrestagung der Deutschen Gesellschaft für Pädiatrische Infektiologie e.V. (DGPI), 08.-10. Juni 2017, Dresden. E-Poster Nr. EPI-P02.
M. Imöhl, M. Laurenz, K. Liebetrau, A. Busse and M. van der Linden.
Microbiological analysis of middle-ear-fluid (MEF) and nasopharyngeal-carriage (NC) of infants with acute otitis media (AOM) in Germany, 7th study year. 35th Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID), Madrid, Spain, 23-27 Mai 2017. E-Poster.
M. van der Linden, S. Perniciaro and M. Imöhl.
Effects of 7 years of immunization with higher-valent pneumococcal conjugate vaccines children in Germany. 35th Annual Meeting
of the European Society for Pediatric Infectious Diseases (ESPID), Madrid, Spain, 23-27 Mai 2017. E-Poster.
S. Perniciaro, M. Imöhl and M. van der Linden.
Population-adjusted effect of pneumococcal conjugate vaccines (PCV7, PCV10 and PCV13) against invasive pneumococcal
disease in children 6 years of age and younger in Germany.
35th Annual Meeting of the European Society for
Pediatric Infectious Diseases (ESPID), Madrid, Spain, 23-27 Mai 2017. E-Poster.
M. van der Linden and M. Imöhl.
Persistent burden of invasive pneumococcal disease in adults in Germany.
27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 22
- 25 April 2017, Vienna, Austria. Poster No: P0063.
2016
M. van der Linden, G. Falkenhorst, S. Perniciaro and M. Imöhl.
Effectiveness of pneumococcal conjugate vaccines (PCV7, PCV10 and PCV13) against invasive pneumococcal disease among children under two years of age in Germany.
68. Jahrestagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie e.V. DGHM, 11. - 14. September 2016, Ulm. Poster No: RKP286.
M. van der Linden S. Perniciaro and M. Imöhl.
Serotype distribution and burden of pneumococcal disease in children and adults in Germany.
10th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-10), June 26-30, 2016, Glasgow, UK. Poster No: 066.
M. van der Linden, M. Imöhl.
Dynamics of serotype 3 among invasive pneumococcal disease in adults in Germany.
10th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-10), June 26-30, 2016, Glasgow, UK. Poster No: 637.
M. van der Linden, J. Hinds, K. Gould, N. Levina, M. Imöhl.
Molecular biological characterization of non-typeable (NT) Streptococcus pneumoniae isolates.
10th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-10), June 26-30, 2016, Glasgow, UK. ePoster.
2015
M. van der Linden, M. Imöhl (Poster):
Ascertainment of pneumococcal vaccination status among children <2 years of age with invasive pneumococcal disease in Germany. 67. Jahrestagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie e.V. DGHM, Münster, 27. – 30. September
2015. Programm, p. 109, RKP 231.
M. Imöhl, M. van der Linden (Poster):
Erhebung des Pneumokokken-Impfstatus bei Kindern unter 2 Jahren mit invasiver Pneumokokkenerkrankung. 111. Jahrestagung der Deutschen Gesellschaft für Kinder- und Jugendmedizin
e.V. (DGKJ), 2. -5. September 2015, München. Hauptprogramm p. 82, Poster Nr.
DGKJ-PO-ID-4.
M. van der Linden, M. Imöhl (Poster):
Effekte nach 6 Jahren höhervalenter Pneumokokken-Konjugatimpfung bei Kindern in Deutschland. 4. Nationale Impfkonferenz, 18.-19. Juni 2015, Berlin. Programm, p. 13, P02-05.
M. Imöhl, M. van der Linden (Poster):
Serotypverteilung und Krankheitslast der Pneumokokkenerkrankungen bei Erwachsenen in Deutschland. 4. Nationale Impfkonferenz, 18.-19. Juni 2015, Berlin. Programm, p. 13, P02-06.
M. van der Linden, M. Imöhl (Short oral
presentation & ePoster):
Effects of 6 years of immunization with higher valent pneumococcal conjugate vaccines in German children. 33rd Annual Meeting of the European Society for Pediatric Infectious Diseases
(ESPID), May 12-16, 2015, Leipzig. Programme Book, page 79, No. 251.
M. van der Linden, M. Imöhl (Poster):
Serotype distribution and burden of pneumococcal disease in adults in Germany. 25th European Congress of Clinical Microbiology and Infectious Diseases
(ECCMID)
April 25-28, 2015, Copenhagen, Denmark. Final Programme, page 112, P186.
M. van der Linden, M. Imöhl (Poster):
Effects of more than 5 years of immunization with higher valent pneumococcal conjugate vaccines in German children. 25th European Congress of Clinical Microbiology and Infectious
Diseases (ECCMID), April 25-28, 2015, Copenhagen, Denmark. Final Programme,page 158, P936.
2014
M. Imöhl, M. van der Linden (Oral presentation):
Serotype distribution and burden of pneumococcal disease in adults in Germany - Reaching the limit of herd protection? 66. Jahrestagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie (DGHM), Dresden, 05.-08. Oktober 2014. Biospektrum, Sonderausgabe 2014, p. 148, RKV05.
M. van der Linden, M. Imöhl (Poster):
Effects of 5 years of immunization with higher valent pneumococcal conjugate vaccines in German children. 66. Jahrestagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie (DGHM), Dresden, 05.-08. Oktober 2014. Biospektrum, Sonderausgabe 2014, p. 347, RKP01.
M.A. Rose, M. Imöhl, M. Laurenz, M van der Linden (Poster):
Veränderung der nasopharyngealen Besiedlung bei Kindern bis zum 5. Lebensjahr in Deutschland seit Einführung der Pneumokokken-Konjugatimpfung. 22. Jahrestagung der Deutschen Gesellschaft für Pädiatrische Infektiologie e.V. (DGPI), 11.-14. September 2014, Leipzig. Poster
Nr. DGPI-PO-ER-4.
M. van der Linden., M. Imöhl (Poster):
Epidemiologie invasiver Pneumokokkenerkrankungen in Deutschland von 1997-2014 bei Kindern: Effekte nach Einführung der höhervalenten Pneumokokken-Konjugatimpfstoffe. 110. Jahrestagung der Deutschen Gesellschaft für Kinder- und Jugendmedizin e.V. (DGKJ), 11.-14. September 2014, Leipzig. Poster Nr. DGKJ-PO-FR-4.
M. Imöhl, M. Bertram,
S. Nyamoya, M. van der Linden (Poster):
Erhebung des Pneumokokken-Impfstatus bei Kindern unter 2 Jahren mit invasiver Pneumokokkenerkrankung. 110. Jahrestagung der Deutschen Gesellschaft für Kinder- und Jugendmedizin e.V.
(DGKJ), 11.-14. September 2014, Leipzig. Poster Nr. DGKJ-PO-FR-3.
M. Imöhl, M. Laurenz, K. Liebetrau, A. Busse, M. van der Linden (Short Oral Presentation):
Microbiological analysis of middle-ear fluid (MEF) and nasopharyngeal carriage (NC) of infants with acute otitis media (AOM) in Germany, 5th study year. 32nd Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), May 06 – 10, 2014, Dublin, Ireland. Finale Programme, No. 312, page 55. Abstract-CD No. 116.
M. van der Linden, M. Imöhl (Poster):
Effects of 5 years of immunization with higher valent pneumococcal conjugate vaccines in German children. 32nd Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), May 06 – 10, 2014, Dublin, Ireland. Finale Programme, No. 784, page 97. Abstract-CD No. 779.
M. van der Linden, M. Bertram, J. Otten, S. Nyamoya, M. Imöhl (Poster):
Ascertainment of pneumococcal vaccination status among children <2 years of age with invasive pneumococcal disease in Germany. 32nd Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), May 06 – 10, 2014, Dublin, Ireland. Finale Programme, No. 785, page 98. Abstract-CD No. 780.
M. van der Linden, M. Imöhl (E-Poster):
Serotype distribution and burden of pneumococcal disease in adults in Germany – reaching the limit of herd protection? 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 10-13 May, 2014, Barcelona, Spain. Final Programme, eP 151, page 97.
M. van der Linden, S. Perniciaro, M. Imöhl (Poster):
Effects of 5 years of immunization with higher valent pneumococcal conjugate vaccines in German children. 9th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD), 09 - 13 March 2014, Hyderabad, India. Abstractband: Pneumonia, Volume 3 (2014), page 201, ISPPD-0142.
M. Imöhl, S. Perniciaro, M. van der Linden (Poster):
Serotype distribution and burden of pneumococcal disease in adults in Germany.
9th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD), 09 - 13 March 2014, Hyderabad, India. Abstractband: Pneumonia, Volume 3 (2014), page 202, ISPPD-0143.
M. van der Linden, D. Ajah, S. Schlösser, T. Vierbuchen, S. Zwirner, J. Otten, N. Levina, C. Heeg, M. Jaschek, M. Imöhl (Poster):
Molecular biological characterization of non-typeable (NT) Streptococcus pneumoniae isolates.
9th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD), 09 - 13 March 2014, Hyderabad, India. Abstractband: Pneumonia, Volume 3 (2014), page 136, ISPPD-0144.
2013
M. van der Linden, M. Imöhl (Poster):
Serotype distribution and vaccine coverage among pneumococcal disease in adults in Germany.
65. Jahrestagung der Deutschen Gesellschaft für
Hygiene und Mikrobiologie (DGHM), Rostock, 22.-25. September
2013. Programm, p. 84, RKP04.
M. Imöhl, M. van der Linden (Poster):
Effects of 4 years of immunization with higher valent pneumococcal conjugate vaccines in German children. 65. Jahrestagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie (DGHM), Rostock, 22.-25. September 2013. Programm, p. 84, RKP05.
M. van der Linden, M. Imöhl (Poster):
Epidemiologie invasiver Pneumokokkenerkrankungen bei Kindern in Deutschland von 1997 – 2013: Effekte nach Einführung der Pneumokokken-Konjugatimpfung.
109. Jahrestagung der Deutschen Gesellschaft für Kinder- und Jugendmedizin (DGKJ),
12. - 15. September 2013, Düsseldorf. Hauptprogramm, Poster-Nr. DGKJ-PO-V1-2, Seite 46.
M. Imöhl, M. Laurenz, K. Liebetrau, A. Busse, M. van der Linden (Poster):
Mikrobiologische Analyse der Mittelohrflüssigkeit (MOF) und Nasopharyngealen Trägerisolate (NTI) bei Kindern mit akuter Otitis media (AOM) in Deutschland, 4. Studienjahr.
109. Jahrestagung der Deutschen Gesellschaft für Kinder- und Jugendmedizin (DGKJ),
12. - 15. September 2013, Düsseldorf. Hauptprogramm, Poster-Nr. DGKJ-PO-V1-3, Seite 46.
M. van der Linden, M. Bertram, J. Otten, M. Imöhl (Poster):
Erhebung des Pneumokokken-Impfstatus bei Kindern unter 2 Jahren mit invasiver Pneumokokkenerkrankung nach Einführung der Pneumokokken-Konjugatimpfung.
109. Jahrestagung der Deutschen Gesellschaft für Kinder- und Jugendmedizin (DGKJ),
12. - 15. September 2013, Düsseldorf. Hauptprogramm, Poster-Nr. DGKJ-PO-V1-4, Seite 46.
M. van der Linden, S.R. Perniciaro, M. Imöhl (Slide Session):
Effects of Four Years of Immunization with Higher Valent Pneumococcal Conjugate Vaccines in German Children and Adults. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Denver, USA, 10-13 September 2013. Final Program, G-1452, page 133.
M. van der Linden, M. Imöhl (Poster):
Microbiological analysis of middle-ear-fluid (MEF) and nasopharyngeal-carriage (NC) of infants with acute otitis media (AOM) in Germany, 4th study year. 31st Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), May 28 – June 1 2013, Milan, Italy. Programme Book, Poster-No. May 31 - 294, page 91.
M. van der Linden, M. Imöhl (Poster + Poster Discussion):
Effects of 3 years of immunization with higher valent pneumococcal conjugate vaccines in German children. 31st Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), May 28 – June 1 2013, Milan, Italy. Programme Book, Poster-No. May 30 - 302, pages 22 + 71.
M. van der Linden, M. Imöhl (Poster):
Effekte nach drei Jahren höhervalenter Pneumokokken-Konjugatimpfung bei Kindern in Deutschland. 3. Nationale Impfkonferenz, München, 15. bis 16. Mai 2013. Abstractband, page 78-79.
M. van der Linden, M. Imöhl (Poster):
Serotypverteilung und Serotypabdeckungsraten der Impfstoffe bei Erwachsenen mit Pneumokokkenerkrankungen. 3. Nationale Impfkonferenz, München, 15. bis 16. Mai 2013. Abstractband, page 79-80.
M. van der Linden, M. Imöhl (ePoster):
Effects of three years of immunisation with higher valent pneumococcal conjugate vaccines in German children. 23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 27-30 April, 2013, Berlin, Germany. Final Programme, eP 735, page 83.
M. Imöhl, M. van der Linden (ePoster):
Serotype distribution and vaccine coverage among pneumococcal disease in adults in Germany.
23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 27-30 April, 2013, Berlin, Germany. Final Programme, eP 737, page 83.
M. van der Linden, M. Imöhl (Poster):
Effekte nach 3 Jahren höhervalenter Pneumokokken-Konjugatimpfung bei Kindern in Deutschland. 21. Jahrestagung der Deutschen Gesellschaft für Pädiatrische Infektiologie e.V., 25.-27. April 2013, Würzburg. Hauptprogramm KS Impf 10, S.127.
2012
M. van der Linden, M. Imöhl (Vortrag):
Effects of three years of immunisation with higher valent pneumococcal
conjugate vaccines on serotype distributions among reported IPD cases in German children and adults.
64. Jahrestagung
der Deutschen Gesellschaft für Hygiene und Mikrobiologie (DGHM), Hamburg, 30. September bis 03. Oktober 2012. Programm, p. 52, RKV03.
M. Imöhl, M. Laurenz, K. Liebetrau, A. Busse, M. van der Linden (Poster):
Mikrobiologische Analyse der Mittelohrflüssigkeit (MOF) und nasopharyngeale Trägerisolate (NTI) bei Kindern mit akuter Otitis media (AOM) in Deutschland, 3. Studienjahr.
108. Jahrestagung der Deutschen Gesellschaft für Kinder- und Jugendmedizin (DGKJ), 12. - 16. September 2012, Hamburg. Hauptprogramm, Poster-Nr. DGKJ-PO-569, Seite 61.
M. van der Linden, M. Imöhl (Poster):
Epidemiologie invasiver Pneumokokkenerkrankungen bei Kindern in Deutschland von 1997 - 2012: Effekte nach Einführung der Pneumokokken-Konjugatimpfung.
108. Jahrestagung der Deutschen Gesellschaft für Kinder- und Jugendmedizin (DGKJ), 12. - 16. September 2012, Hamburg. Hauptprogramm, Poster-Nr. DGKJ-PO-565, Seite 61.
M. van der Linden, R. von Kries, M. Imöhl (Poster):
Effects of three years of immunization with higher valent pneumococcal conjugate vaccines on serotype distributions among reported IPD cases in German children and adults.
52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, USA, 9-12 September 2012. Final Program, G-863, page 101.
M. Imöhl, M. Laurenz, K. Liebetrau, A. Busse, M. von der Linden (Poster):
Microbiological analysis of middle ear fluid (mef) and nasopharyngeal carriage (nc) of infants with AOM in Germany, third study-year. 30th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), 8 - 12 May 2012, Thessaloniki, Greece. Programme Book, Poster-No. 460, page 59.
M. van der Linden, R. von Kries, M. Imöhl (Poster):
Effects of immunization with higher valent pneumococcal conjugate vaccines in German children on numbers of reported IPD cases (1997 – 2012). 30th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), 8 - 12 May 2012, Thessaloniki, Greece. Programme Book, Poster-No. 680, page 73.
M. van der Linden, M. Imöhl (Poster):
Epidemiologie invasiver Pneumokokkenerkrankungen bei Kindern in Deutschland von 1997-2012: Effekte nach Einführung der Pneumokokken-Konjugatimpfung.
20. Jahrestagung der Deutschen Gesellschaft für Pädiatrische Infektiologie e.V., 19.-21. April 2012, Mannheim. Hauptprogramm PO-04, S.22.
M. Imöhl, M. Laurenz, K. Liebetrau, A. Busse, M. von der Linden (Poster):
Mikrobiologische Analyse der Mittelohrflüssigkeit (MOF) und Nasopharyngeale Trägerisolate (NTI) bei Kindern mit akuter Otitis media (AOM) in Deutschland, 3. Studienjahr.
20. Jahrestagung der Deutschen Gesellschaft für Pädiatrische Infektiologie e.V., 19.-21. April 2012, Mannheim. Hauptprogramm PO-05, S.22.
M. van der Linden, M. Imöhl (Poster):
Serotype distribution among bacteremic pneumococcal pneumonia in adults in Germany.
22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 - April 3, 2012, London, United Kingdom. Final Programme, P 1029.
M. van der Linden, M. Imöhl (Poster):
Effects of childhood vaccination on serotype distribution and coverage of PCV13 among adults in Germany. 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 - April 3, 2012, London, United Kingdom. Final Programme, P 1032.
M. van der Linden, M. Imöhl (Poster):
Effects of immunization with higher valent pneumococcal conjugate vaccines in German children on numbers of reported IPD cases. 8th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD), 11 - 15 March 2012, Iguacu Falls, Brazil. Program Book, page 64.
2011
M. van der Linden, M. Imöhl (Poster):
Reduction of antibiotic resistance among S. pneumoniae isolated from IPD in children and adults
as a result of the German National Immunization program for pneumococcal conjugate vaccine.
63. Jahrestagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie (DGHM), Düsseldorf und Essen, 25. bis 28. September 2011. International Journal of Medical Microbiology (IJMM), Vol. 301, Suppl. 1, RKP06, S. 109.
M. van der Linden, M. Imöhl (Poster):
Epidemiologie invasiver Pneumokokkenerkrankungen bei Kindern in Deutschland von 1997 - 2010: Effekte nach Einführung der Pneumokokken-Konjugatimpfung. 107. Jahrestagung der Deutschen Gesellschaft für Kinder - und Jugendmedizin e. V. / DGKJ, 22. bis 25. September 2011, Bielefeld, Programm, DGKJ-PO-85, S. 145.
M. van der Linden, M. Imöhl, R. Sprenger, K. Liebetrau, A. Busse (Poster):
Nasopharyngeale Trägerisolate (NTI) von Kindern mit akuter Otitis media (AOM) in Deutschland, 2. Studienjahr. 107. Jahrestagung der Deutschen Gesellschaft für Kinder und Jugendmedizin e. V. / DGKJ, 22. bis 25. September 2011, Bielefeld, Programm, DGKJ-PO-86, S. 145.
M. Imöhl, U. Weigel, K. Liebetrau, A. Busse, M. van der Linden (Poster):
Mikrobiologische Analyse der Mittelohrflüssigkeit bei Kindern mit akuter Otitis media (AOM) in Deutschland, 2. Studienjahr. 107. Jahrestagung der Deutschen Gesellschaft für Kinder und Jugendmedizin e. V. / DGKJ, 22. bis 25. September 2011, Bielefeld, Programm, DGKJ-PO-87, S. 145.
M. van der Linden, R. von Kries, S. Rückinger, M. Imöhl (Poster):
First Effects of Immunization with Higher Valent Pneumococcal Conjugate Vaccines in German Children on Numbers of Reported Invasive Pneumococcal Disease (IPD) cases.
51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, USA, 17-20 September 2011. Final Program, G3-775, page 95.
M. van der Linden, M. Imöhl (Poster):
Effects of immunization with pneumococcal conjugate vaccines in German children on numbers of reported IPD cases. EuroPneumo, 10th European Meeting on the Molecular Biology of the Pneumococcus, the Royal Netherlands Society of Arts and Sciences, 23 - 26 June 2011, Amsterdam, The Netherlands, Program and abstracts, P36, page 113.
M. van der Linden, R. R. Reinert, M. Imöhl (Poster):
Clonal distribution of isolates from IPD in German children before and after introduction of PCV7. EuroPneumo, 10th European Meeting on the Molecular Biology of the Pneumococcus, the Royal Netherlands Society of Arts and Sciences, 23 - 26 June 2011, Amsterdam, The Netherlands, Program and abstracts, P 50, page 130.
M. Imöhl, U. Weigel, K. Liebetrau, A. Busse, M. van der Linden (e-Poster):
Etiology of middle ear fluid of infants with acute otitis media (AOM) in Germany, 2nd study year. 29. Annual Meeting of the European Society for Paediatric Infectious Diseases, The Hague, The Netherlands, June 07-11, 2011. Abstract 714, Programme book, P 497, page 28+71.
M. Imöhl, R. Sprenger, K. Liebetrau, A. Busse, M. van der Linden (e-Poster):
Nasopharyngeal carriage isolates (NCI) from infants with acute otitis
media (AOM) in Germany. 29. Annual Meeting of the European Society for Paediatric
Infectious Diseases, The Hague, The Netherlands, June 07-11, 2011. Abstract 718, Programme, P 498, page
71.
M. van der Linden, M. Imöhl, R. von Kries, S. Rückinger (Poster):
First effects of immunization with higher valent pneumococcal conjugate vaccines in German children on numbers of reported IPD cases. 29. Annual Meeting of the European Society for Paediatric Infectious Diseases, The Hague, The Netherlands, June 07-11, 2011. Abstract 892, Programme, P 743, page 87.
M. van der Linden, M. Imöhl (Publication):
Serotype distribution among bacteremic pneumococcal pneumonia in adults in Germany.
21th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Milan, Italy, 7-10 May 2011. Clin Microbiol Infect. 2011 May; Volume 17, Suppl S4, R2762.
M. van der Linden, M. Imöhl (Poster):
Invasive Pneumokokken-Erkrankungen bei Erwachsenen in Deutschland.
117. Kongress der Deutschen Gesellschaft für Innere Medizin, Wiesbaden, 30. April bis 4. Mai 2011, Hauptprogramm, p. 280, PS 367.
M. van der Linden, M. Imöhl (Poster):
Effekte des Kinderimpfprogrammes auf die Verteilung von Pneumokokkenserotypen bei Erwachsenen. 19. Jahrestagung der Deutschen Gesellschaft für pädiatrische Infektiologie (DGPI), Leipzig, 31. März bis 2. April 2011. Hauptprogramm, PO-38, page 28.
M. van der Linden, M. Imöhl (Poster):
Epidemiologie invasiver Pneumokokkenerkrankungen bei Kindern in Deutschland von 1997-2010: Effekte nach Einführung der Pneumokokken-Konjugatimpfung. 19. Jahrestagung der Deutschen Gesellschaft für pädiatrische Infektiologie (DGPI), Leipzig, 31. März bis 2. April 2011. Hauptprogramm, PO-40, page 29.
M. van der Linden, M. Imöhl (Poster):
Invasive Pneumokokken-Erkrankungen bei Erwachsenen in Deutschland: Bestandsaufnahme vier Jahre nach Einführung der Pneumokokken-Konjugatimpfung bei Kindern. 2. Nationale Impfkonferenz, Stuttgart, 8. bis 9. Februar 2011. Abstractband, P 49, page 48.
2010
M. van der Linden, R.R. Reinert and M. Imöhl (Vortrag + Poster):
Effects of four years of PCV7 immunization in German children. 14th Scientific Meeting of the European Society of Chemotherapy / Infectious Diseases, Vienna, December 8-11, 2010. Book of Abstracts, P 19, page 3.
M. van der Linden, A. Siedler, R. von Kries, M. Imöhl, R.R. Reinert, S. Rückinger (Poster):
Effects of Four Years of PCV7 Immunization in German Children on Numbers of Reported Cases and on Incidence of IPD. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Boston, USA, 12-15 September 2010. Final Program, G1-886, page 70.
M. Imöhl, R.R. Reinert, M. van der Linden (Poster):
Macrolide susceptibility of Streptococcus pneumoniae in Germany (1992-2008). 28th Annual Meeting of the European Society for Paediatric Infectious Diseases, Nice, France, May 4-8, 2010. Programme Book, P 5, page 37.
S. Rückinger, A. Siedler, R. von Kries, R.R. Reinert, M. Imöhl, M. van der Linden (Poster):
Further incidence trends of invasive pneumococcal disease more than 2 years after introduction of 7-valent pneumococcal conjugate vaccination in Germany. 28th Annual Meeting of the European Society for Paediatric Infectious Diseases, Nice, France, May 4-8, 2010. Programme Book, P 370, page 64.
M. van der Linden, M. Imöhl, R. Sprenger, K. Liebetrau, A. Busse (Poster):
Etiology of nasopharyngeal carriage isolates from infants with acute otitis media (AOM) in Germany. 28th Annual Meeting of the European Society for Paediatric Infectious Diseases, Nice, France, May 4-8, 2010. Programme Book, P 376, page 64.
M. van der Linden, M. Imöhl, U. Weigel, K. Liebetrau, A. Busse (Poster):
Etiology of middle ear fluid of infants with acute otitis media (AOM) in Germany. 28th Annual Meeting of the European Society for Paediatric Infectious Diseases, Nice, France, May 4-8, 2010. Programme Book, P 377, page 64.
M. Imöhl, R.R. Reinert, M. van der Linden (Poster):
Temporal variations among invasive pneumococcal disease serotypes in children and adults and pneumococcal vaccine coverages in Germany from 1992 to 2008. 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienna, Austria, 10-13 April 2010. Clin Microbiol Infect. 2010 Apr; Volume 16, Issue s2, P1958.
M. van der Linden, R.R. Reinert, M. Imöhl (Poster):
Immunization with the 7-valent pneumococcal conjugate vaccine in children leads to herd immunity among adults in Germany. 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienna, Austria, 10-13 April 2010. Clin Microbiol Infect. 2010 Apr; Volume 16, Issue s2, P2020.
M. Imöhl, R.R. Reinert, M. van der Linden (Poster):
Serotype specific penicillin resistance of Streptococcus pneumoniae in Germany from 1992 to 2008. 3. Gemeinsame Tagung von DGHM und VAAM (62. Jahrestagung der DGHM und VAAM-Jahrestagung 2010), Hannover, 28.-31. März 2010. Biospektrum, Sonderausgabe 2010, RKP07, page 255.
M. van der Linden, J. Elias, M. Imöhl, H. Claus, M. Frosch, U. Vogel (Poster):
Invasive bacterial infections in the elderly: data from the IBI network. 3. Gemeinsame Tagung von DGHM und VAAM (62. Jahrestagung der DGHM und VAAM-Jahrestagung 2010), Hannover, 28.-31. März 2010. Biospektrum, Sonderausgabe 2010, RKP09, page 255.
M. van der Linden, R. von Kries, M. Imöhl, R.R. Reinert, S. Rückinger (Vortrag):
Effects of the pneumococcal conjugate vaccination on IPD in children and adults in Germany.
3. Gemeinsame Tagung von DGHM und VAAM (62. Jahrestagung der DGHM und VAAM-Jahrestagung 2010), Hannover, 28.-31. März 2010. Biospektrum, Sonderausgabe 2010, RKV02, page 258.
M. van der Linden, M.W.R. Pletz, M. Imöhl (Poster): Serotype distribution and vaccine coverage among adults with pneumococcal disease in Germany. 51. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V., Hannover, 17.-20. März 2010. Hauptprogramm, P450, page 106.
M. van der Linden, S. Rückinger, R. von Kries, M. Imöhl, R.R. Reinert (Vortrag + Poster):
Increased disease awareness after onset of a national immunization program with 7-valent pneumococcal conjugate vaccine. 7th international symposium on pneumococci and pneumococcal diseases (ISPPD-7), Tel Aviv, Israel, March 14-18, 2010. Book of Abstracts, P 124, page 247-248.
M. van der Linden, R.R. Reinert, M. Imöhl (Poster):
Herd immunity among adults as a consequence of the national immunization programme with pneumococcal conjugate vaccine for children in Germany. 7th international symposium on pneumococci and pneumococcal diseases (ISPPD-7), Tel Aviv, Israel, March 14-18, 2010. Book of Abstracts, P 141, page 258-259.
M. van der Linden, R.R. Reinert, M. Imöhl (Poster):
Clonal distribution of isolates from IPD in German children before and after introduction of PCV7. 7th international symposium on pneumococci and pneumococcal diseases (ISPPD-7), Tel Aviv, Israel, March 14-18, 2010. Book of Abstracts, P 142, page 259.
M. van der Linden, R.R. Reinert, M. Imöhl (Poster):
Epidemiology of serotype 6C in invasive pneumococcal disease in Germany. 7th international symposium on pneumococci and pneumococcal diseases (ISPPD-7), Tel Aviv, Israel, March 14-18, 2010. Book of Abstracts, P 143, page 259-260.
2009
M. van der Linden, R.R. Reinert, M.
Imöhl (Poster):
The National Immunization Programme for pneumococcal conjugate vaccine in Germany -
first signs of a herd immunity effect in adults. 61. Jahrestagung der Deutschen Gesellschaft für Hygiene und
Mikrobiologie (DGHM), Göttingen, 20. bis 23. September 2009. International Journal
of Medical Microbiology, Sept. 2009, Vol. 299, Suppl. 1, page 85.
M. Imöhl, R.R. Reinert, M. van der Linden (Vortrag):
Regional differences of invasive pneumococcal disease among German federal states in serotype distribution, pneumococcal vaccine coverage and antimicrobial resistance. 61. Jahrestagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie (DGHM), Göttingen, 20. bis 23. September 2009. International Journal of Medical Microbiology, Sept. 2009, Vol. 299, Suppl. 1, page 99.
M. Imöhl, R.R. Reinert, M. van der Linden (Poster):
Annual report of the National Reference Centre for Streptococci, 2008. 61. Jahrestagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie (DGHM), Göttingen, 20. bis
23. September 2009. International Journal of Medical Microbiology, Sept. 2009, Vol. 299,
Suppl. 1, page 98.
M. van der Linden, A. Siedler, F. Burckhardt, R. von Kries, M.
Imöhl, R.R. Reinert, S. Rückinger (Poster):
Reduction of IPD in children as a result of the German National Immunization program for pneumococcal conjugate vaccine. 61. Jahrestagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie (DGHM), Göttingen, 20. bis 23. September 2009. International Journal of Medical Microbiology, Sept. 2009, Vol. 299, Suppl. 1, page 86.
M. van der Linden, A. Siedler, F. Burckhardt, R. von Kries, M.
Imöhl, R.R. Reinert, S. Rückinger (Poster):
The German National Immunization program for pneumococcal conjugate vaccine results in strong reduction of IPD in children. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy
(ICAAC), San Francisco, USA, September 12-15, 2009. Final Program, Poster G1-875, page 57.
M. van der Linden, M. Imöhl, R. von Kries, A. Siedler, R.R. Reinert, S. Rückinger
(Poster):
Epidemiologie invasiver Pneumokokkenerkrankungen bei Kindern in Deutschland von 1997-2009, Effekte der Einführung der Pneumokokken-Konjugatimpfung. 105. Jahrestagung Deutsche Gesellschaft für
Kinder- und Jugendmedizin (DGKJ), Mannheim, 3. bis 6. September 2009. Monatsschrift Kinderheilkunde, Abstracts 2009, Vol. 157, Suppl. 1, DGKJ PO 234, page 122.
M. Imöhl, R.R. Reinert, M. van der Linden (Poster):
New penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effects on susceptibility categorisation in Germany from 1992 to 2008. 27. Annual Meeting of the
European Society for Paediatric Infectious Diseases, Brussels, Belgium, June 09-13, 2009. Programme, P 202, page 54.
M. van der Linden, A. Siedler, F. Burckhardt, R. von Kries, M.
Imöhl, R.R. Reinert, S. Rückinger (Poster):
National Immunization Program for Prevenar (PCV7) results in Reduction of Incidence of IPD in German Children. 27. Annual Meeting of the European Society for Paediatric Infectious Diseases,
Brussels, Belgium, June 09-13, 2009. Programme, P 142, page 104.
M. Imöhl, R.R. Reinert, M. van der Linden (Poster):
Adult invasive pneumococcal disease in North-Rhine Westphalia, Germany, 2003-2006: Serotype distribution before recommendation of general pneumococcal conjugate vaccination for children < 2
years of age. 19. European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland, May 16-19, 2009. Clinical Microbiology and Infection, 2009, Suppl. 4, P 932, page
242.
M. van der Linden, R.R. Reinert, M.
Imöhl (Poster):
Invasive pneumococcal disease among adults in Germany after the start of the National Immunization Programme for the 7 valent pneumococcal conjugate vaccine in children. 19. European Congress of
Clinical Microbiology and Infectious Diseases, Helsinki, Finland, May 16-19, 2009. Clinical Microbiology and
Infection, 2009, Suppl. 4, P 1129, page 303.
M. Imöhl, R.R.
Reinert, M. van der Linden (Poster):
Invasive Pneumokokken-Erkrankungen bei Erwachsenen in Deutschland - Mögliche Herdenimmunitätseffekte nach Einführung der Pneumokokken-Konjugatimpfung bei Kindern. 17. Jahrestagung der Deutschen
Gesellschaft für pädiatrische Infektiologie (DGPI), Bremen, 2. bis 4. April 2009. Programm, P 26, page 26.
M. Imöhl, M. van der
Linden, R. von Kries, A. Siedler, R.R. Reinert, S. Rückinger (Poster):
Epidemiologie invasiver Pneumokokkenerkrankungen bei Kindern in Deutschland von 1997-2009, Effekte der Einführung der Pneumokokken-Konjugatimpfung. 17. Jahrestagung der Deutschen Gesellschaft für
pädiatrische Infektiologie (DGPI), Bremen, 2. bis 4. April 2009. Programm, P 27, page 26.
M. van der Linden, R. Reinert, M. Imöhl (Poster):
Invasive Pneumokokken-Erkrankungen bei Erwachsenen in Deutschland: Mögliche Herdenimmunitätseffekte nach Einführung der Pneumokokken-Konjugatimpfung bei Kindern. 1. Nationale Impfkonferenz,
Mainz, 5. bis 7. März 2009. Abstractband, PS 46, page 35.
M. van der Linden, M. Imöhl, R. von Kries, A. Siedler, R.R. Reinert, S. Rückinger
(Poster):
Epidemiologie invasiver Pneumokokkenerkrankungen bei Kindern in Deutschland von 1997-2009, Effekte der
Einführung der Pneumokokken-Konjugatimpfung. 1. Nationale Impfkonferenz, Mainz, 5. bis 7. März 2009. Abstractband, PS 45, page 35.
2008
M. van der Linden, M. Imöhl, R.R. Reinert (Poster, Gewinner des
Posterpreises):
Impact of the national immunization program for PCV7 on IPD among German children. 13th
Scientific Meeting of the European Society of Chemotherapy / Infectious Diseases, Vienna, December 3-6, 2008. Final Program, P 25, page 40.
M. van der Linden, M. Imöhl, R.R. Reinert
(Poster):
Surveillance of IPD in children in Germany 2004 - 2008, first results of the German national immunization program for PCV7. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, USA, October
25-28, 2008. Abstract book, G-2110, page 365.
M. van der Linden, M. Imöhl, R.R. Reinert
(Vortrag):
IPD in children in Germany 2004-2008, impact of the national immunization program for PCV7. 60. Jahrestagung der
Deutschen Gesellschaft für Hygiene und Mikrobiologie (DGHM), Dresden, 21. bis 24. September 2008. International Journal of Medical Microbiology, 2008, Vol. 298, Suppl. 2, page 105.
M. Imöhl, R.
Lütticken, R.R. Reinert, M. van der Linden (Vortrag):
Epidemiology and antimicrobial susceptibility of invasive S. pyogenes disease in Germany (2003-2007). 60. Jahrestagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie (DGHM), Dresden,
21. bis 24. September 2008. International Journal of Medical Microbiology, 2008, Vol.
298, Suppl. 2, page 105.
M. van der Linden, M. Imöhl, R.R. Reinert
(Poster):
Potential impact of 7 valent pneumococcal conjugate vaccine on the incidence of invasive pneumococcal disease among adults in Germany, first results from enhanced
surveillance. 60. Jahrestagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie (DGHM), Dresden, 21. bis
24. September 2008. International Journal of Medical Microbiology, 2008, Vol. 298,
Suppl. 2, page 102.
M. van der Linden, C. Heeg, M. Imöhl, R.R. Reinert
(Poster):
Annual report of the National Reference Centre for Streptococci, 2007. 60. Jahrestagung der Deutschen Gesellschaft für
Hygiene und Mikrobiologie (DGHM), Dresden, 21. bis 24. September 2008. International
Journal of Medical Microbiology, 2008, Vol. 298, Suppl. 2, page 102.
M. Imöhl, R. Lütticken, R.R. Reinert, M. van der Linden (Poster):
Epidemiology of invasive S. pyogenes disease in Germany. XVII Lancefield International Symposium on Streptococci & Streptococcal Diseases, Porto Heli, Greece, June 22-26, 2008. Abstract book,
P 45C, page 139.
Weber D., Johnen G., Taeger D., Pesch B., Imöhl M., Kraus T., Verch T., Brüning T (Poster):
Einfluß von biologischen und präanalytischen Faktoren auf SMRP („soluble mesothelin-related proteins“) im Serum. 47. Jahrestagung der Deutschen Gesellschaft für Arbeitsmedizin und Umweltmedizin, Mainz, 21. bis 24. März 2007. Arbeitsmed. Sozialmed. Umweltmed. 2007; 42(3): 160.
2006
Kraemer U., Cao Y., Winneke G., Wittsiepe J., Imoehl M., Eberwein H.G., Ranft U., Furst P., Wilhelm M (Vortrag): Prenatal exposure to organochlorine chemicals at environmental levels has a negative impact on sex steroids in newborns. International Conference on Environmental Epidemiology & Exposure, 2-6 September 2006, Paris. Epidemiology 2006; 17 (Suppl. 6), S192.
Johnen G., Weber D.G., Imöhl M., Verch T., Sardesai N.Y. Brüning T (Vortrag):
Mesothelin - ein neuer Serummarker für die Frühdiagnostik von Mesotheliomen. 46. Jahrestagung der Deutschen Gesellschaft für Arbeitsmedizin und Umweltmedizin, Hannover, 22. bis 25. März 2006. Arbeitsmed. Sozialmed. Umweltmed. 2006; 41(3): 109-110.
2005
Cao Y., Winneke G., Eberwein H.G., Fürst P., Imöhl M., Kraft M., Ranft U., Wilhelm M., Wittsiepe J., Krämer U (Vortrag & Poster): Negative associations between prenatal exposure to organohalogen compounds and sex steroids in newborns. Konferenz des EU-Projektes ’Policy Interpretation Network on Children's Health and Environment (PINCHE)’, 23.-25. November 2005, Brüssel.
2003
Grootoonk S., de Zeeuw J., Walther J.W., Imöhl M., Krieg M., Duchna H.-W., Orth M.,
Schultze-Werninghaus G. (Poster): Erhöhte Aktivität der Creatinkinase bei Patienten mit obstruktivem
Schlafapnoe-Syndrom (OSAS). 44. Kongress der Deutschen Gesellschaft für Pneumologie, 26.-29. März 2003, München. Pneumologie 2003; 57: S63.
Imöhl M., Köditz R., Stachon A., Pfeilschifter J., Krieg M (Poster): Hereditäre, ACTH-unabhängige, bilaterale makronoduläre Nebennierenrindenhyperplasie - Diagnosefindung und Verlauf anhand einer Falldarstellung. Jahrestagung der Nordrhein-Westfälischen Gesellschaft für Endokrinologie und Diabetologie, Paderborn 2003.
2001
Imöhl M., Krieg M. (Poster): Dependence of S-ß2-microglobulin on age and hospitalization.
XXI. World Congress of Pathology and Laboratory Medicine, 20.-23. November 2001, Düsseldorf, Germany. Clin Lab 2001; 47: 611.
Imöhl M., Köditz R., Stachon A., Krieg M. (Poster): ACTH-independent bilateral macronodular hyperplasia of the adrenal cortex – a case report. Joint Meeting of the German Society of Clinical Chemistry and of the German Society of Laboratory Medicine, 16-19 September 2001, Rostock, Germany. Clin Chem Lab Med 2001; 39: A44.
Imöhl M., Krieg M. (Poster): Dependence of S-ß2-microglobulin on age, hospitalization, and inflammation. Joint Meeting of the German Society of Clinical Chemistry and of the German Society of Laboratory Medicine, 16-19 September 2001, Rostock, Germany. Clin Chem Lab Med 2001; 39: A43-44.